The partnership with Vesalio is strategically significant for Transmedic as it strengthens our position as a leading provider of advanced vascular solutions in Southeast Asia and Hong Kong. This collaboration allows Transmedic to integrate Vesalio’s proprietary NeVa™, enVast™, and pVasc™ platforms into our diverse cardiovascular and neurological portfolios.